PVT1 and asthma: When PVT1 was targeted with siRNAs in ASMCs from patients with severe asthma, the FCS plus TGF-β– and dexamethasone plus FCS plus TGF-β–induced c-MYC expression was returned to basal levels (Fig 4, F).